London (UK), 20 June 2022 Ian King interviews Pharmavovia’s CEO, Dr James Burt on SkyNews
More informationPharmanovia has acquired the commercial rights in China for Rocaltrol® (calcitriol) Roche. Pharmanovia obtained the...
More informationThe report celebrates the firm’s diversity and sets out ambitious environmental and sustainability targets London, UK...
More informationLONDON – Alastair Hay is leaving his position as Chief Corporate Development Officer at the global...
More informationPharmanovia officially welcomes Lamepro B.V into the group Basildon (UK), 28 February 2022 – Pharmanovia, The life...
More informationBasildon (UK), 10 November 2021 – Pharmanovia, the original medicines specialist globally, today announced that its...
More informationBasildon (UK), 8 September 2021 – Pharmanovia, the original medicines specialist globally, in conjunction with their...
More informationBasildon (UK), 30 July, 2021 – Pharmanovia is proud to announce their first global charity partnership...
More informationBasildon (UK), 20 July, 2021 – m8 Pharmaceuticals and Pharmanovia have signed an exclusive licensing agreement...
More informationFor all media enquiries please contact: communications@pharmanovia.com